FOXD3-AS1 was found to be up-regulated in breast malignant tumor and was correlated with advanced clinical stages, and silence of FOXD3-AS1 significantly attenuated the breast cancer cell proliferation and metastasis [13]. The gene discussed is FOXD3; the disease is breast carcinoma.